Phong Phu Pharmaceutical JSC
VN:PPP
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
16 500
22 900
|
| Price Target |
|
We'll email you a reminder when the closing price reaches VND.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Net Margin
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Peer Comparison
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| VN |
P
|
Phong Phu Pharmaceutical JSC
VN:PPP
|
171.6B VND |
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
982.2B USD |
Loading...
|
|
| UK |
|
Dechra Pharmaceuticals PLC
LSE:DPH
|
440.4B GBP |
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
526.1B USD |
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
276.2B CHF |
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
215.4B GBP |
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
221.7B CHF |
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
270.7B USD |
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.7T DKK |
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD |
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
145.8B USD |
Loading...
|
Market Distribution
| Min | -67 046.2% |
| 30th Percentile | 1.4% |
| Median | 4% |
| 70th Percentile | 9.8% |
| Max | 1 155.9% |
Other Profitability Ratios
Phong Phu Pharmaceutical JSC
Glance View
Phong Phu Pharmaceutical JSC engages in the pharmaceutical industry business. The company is headquartered in Ho Chi Minh, Ho Chi Minh. The company went IPO on 2011-07-18. The firm manufactures, imports and trades pharmaceutical products. Its pharmaceutical manufacturing factory is located at Binh Tan District, Ho Chi Minh City. The company also has a pharmaceutical manufacturing workshop located at District 8, Ho Chi Minh City. The firm is also involved in the manufacturing and trading of milk and its derived products, as well as bread, cake, chocolate, sweets, jam, pasta, noodles, tea, drinking water and non-alcoholic beverages. In addition, it manufactures functional food and trades cosmetic products. The firm is engaged in the provision of trucking services, bus services and car rental services as well.
See Also
Net Margin is calculated by dividing the Net Income by the Revenue.
The current Net Margin for Phong Phu Pharmaceutical JSC is 11%, which is below its 3-year median of 11.8%.
Over the last 3 years, Phong Phu Pharmaceutical JSC’s Net Margin has decreased from 13.6% to 11%. During this period, it reached a low of 11% on Oct 30, 2025 and a high of 13.6% on Aug 30, 2022.